99mTc-DPD显像心肌摄取并非都是淀粉样变:氯喹致心肌病一例
本文报道一例61岁女性,有高血压及类风湿关节炎病史,长期服用氯喹10年,因心衰入院。超声示严重向心性左室肥厚,免疫固定电泳及轻链阴性,心脏磁共振未见延迟钆增强。99mTc-DPD显像示心肌摄取(Perugini 2/3级),基因检测排除遗传性转甲状腺素蛋白心肌淀粉样变,心内膜心肌活检未见淀粉样变证据而与氯喹毒性一致。提示骨显像心肌摄取需结合用药史鉴别。
要点
- 99mTc-DPD心肌摄取(Perugini 2/3级)也可见于氯喹诱导的心肌病,并非淀粉样变特异。
- 长期氯喹用药史者出现心衰和左室肥厚时,应警惕药物性心肌病。
- 基因检测与心内膜心肌活检有助于排除转甲状腺素蛋白心肌淀粉样变。
核心结论
- 99mTc-DPD显像心肌摄取并非淀粉样变所特有,氯喹介导的心脏毒性可表现为心肌摄取,需结合用药史与活检鉴别。
研究设计与样本
- 单例病例报告:61岁女性,高血压及类风湿关节炎病史,服用氯喹10年,因心衰入院。
主要发现
- 超声示严重向心性左室肥厚,血清和尿免疫固定电泳及血清轻链检测阴性,心脏磁共振未见延迟钆增强。
- 99mTc-DPD显像示心肌摄取(Perugini评分2/3级),基因检测排除遗传性转甲状腺素蛋白心肌淀粉样变。
- 心内膜心肌活检未见淀粉样变证据,结果与氯喹毒性一致。
关键数值与推荐
- 99mTc-DPD显像心肌摄取Perugini评分2/3级;基因检测排除遗传性转甲状腺素蛋白心肌淀粉样变;心内膜心肌活检不支持淀粉样变、符合氯喹毒性。
临床怎么用
- 对骨显像示心肌摄取者应询问氯喹等药物史,必要时行基因检测与心内膜心肌活检以排除淀粉样变。
局限性
- 为单例病例报告,氯喹心肌毒性的骨显像影像特征报道极少,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This was the case of a 61-year-old woman with a medical history significant for hypertension and rheumatoid arthritis treated with chloroquine for the last 10 years. She was admitted to our hospital for heart failure symptoms. Echocardiography revealed severe concentric left ventricular hypertrophy. Serum and urine immunofixation electrophoresis and serum light chain assay were negative. No late gadolinium enhancement was observed on cardiovascular magnetic resonance. 99mTc-99mTc-DPD (3,3-diphosphono-1,2-propanodicarboxylic acid) scintigraphy showed myocardial uptake (Perugini score 2/3). Genetic testing excluded hereditary transthyretin cardiac amyloidosis. Endomyocardial biopsy analysis did not show findings suggestive of amyloidosis but consistent with chloroquine toxicity. Chloroquine-mediated cardiotoxicity is rare, and there are very few reports about bone scintigraphy imaging features.
引用
- Wakfie-Corieh CG, Ramos López N, Saiz-Pardo Sanz M, et al. Not All Heart Uptakes on 99mTc-DPD Scintigraphy Are Amyloidosis: Chloroquine-Induced Cardiomyopathy. Clin Nucl Med. 2021. PMID: 33208614. doi:10.1097/RLU.0000000000003387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。